(Q51382768)

English

Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice.

scientific article published in April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

1 reference

ChEBI release 2020-05-28

author name string

X Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

Z Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

Y Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

J Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

13

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

337-347

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Protection of pancreatic beta-cells: is it feasible?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Metabolic and molecular basis of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Molecular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Biology of incretins: GLP-1 and GIP

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

GLP-1 and type 2 diabetes: physiology and new clinical advances

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

The intersection of safety and adherence: new incretin-based therapies in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Large scale isolation, growth, and function of porcine neonatal islet cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

beta cell cytoprotective strategies: establishing the relative roles for iNOS and ROS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a beta-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Distribution of AQP2 and AQP3 water channels in human tissue microarrays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Induction by glucose of genes coding for glycolytic enzymes in a pancreatic beta-cell line (INS-1).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

NeuroD1 in the endocrine pancreas: localization and dual function as an activator and repressor.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01354.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2010.01354.X

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21205126

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51382768&oldid=1198710021"